LUZACNE is being developed as a PDT option for a highly unmet need in the segment of moderate to severe acne.
As compared to standard acne therapies, LUZACNE aims to achieve:
- Improvement in efficacy;
- Better tolerability;
- Prolonged duration of therapeutic effects;
- Non-development of microbial resistance;
- Non-interference in female hormone system;
- Better patient compliance.
LUZACNE project (Project No. 30218) has benn partially funded by Quadro de Referência Estratégica Nacional (QREN).